Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 2, 2001, Pages 262-269

  Winters, Stephen L ^{a,b,c,d,e,f,g,h,i,j}   Packer, Douglas L ^{a,b,c,d,e,f,g,h,i,j}   Marchlinski, Francis E ^{a,b,c,d,e,f,g,h,i,j}   Lazzara, Ralph ^{a,b,c,d,e,f,g,h,i,j}   Cannom, David S ^{a,b,c,d,e,f,g,h,i,j}   Breithardt, Günter E ^{a,b,c,d,e,f,g,h,i,j}   Wilber, David A ^{a,b,c,d,e,f,g,h,i,j}   John Camm, A ^{a,b,c,d,e,f,g,h,i,j}   Ruskin, Jeremy N ^{a,b,c,d,e,f,g,h,i,j}  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

^b ST MARY S HOSPITAL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e GOOD SAMARITAN HOSPITAL   (United States)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j NASPE c/o Marilyn Bishop   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COST; DEFIBRILLATOR; FOLLOW UP; HOSPITAL DISCHARGE; PATIENT MONITORING; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION;

EID: 0035093580     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00262.x     Document Type: Review

References (35)

1. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association task force on practice guidelines
2. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
3. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
4. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Hamburg (CASH) Study
5. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
6. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee On clinical Intracardiac Electrophysiological and Catheter Ablation procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology
7. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope
8. High incidence of appropriate cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible arrhythmias
9. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
10. A randomized study of the prevention of sudden death in patients with coronary artery disease
11. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass surgery
12. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome
13. Implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease
14. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts
15. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
16. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction. SCD-HEFT and MADIT II
17. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)
18. Multicenter Automatic Defibrillator Implantation Trial II (MADITII);Design and clinical protocol
19. Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology
20. Recommended guidelines for training in adult clinical cardiac electrophysiology
21. Safety of nurse-administered deep sedation for defibrillator implantation in the electrophysiology laboratory
22. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators
23. Recommendations for qualification of centers implanting and following defibrillators
24. Effects of an active pectoralpulse generator shell on defibrillation energy with a transvenous lead system
25. Increases in defibrillation threshold in nonthoracotomy implantable defibrillators using a biphasic waveform
26. Utility of predischarge and one-month transvenous implantable defibrillator tests
27. Management of ventricular arrhythmias
28. Sudden cardiac death: Structure, function, and time-dependence of risk
29. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest
30. Treatment for ventricular fibrillation: Emergency medical technician defibrillation and paramedic services
31. Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the "Ulstein style."
32. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study
33. An analysis of the cost effectiveness of the implantable defibrillator